HSIC Henry Schein, Inc. - Common Stock
Über Henry Schein, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Henry Schein, Inc. ist ein im Jahr 1932 gegründeter US-amerikanischer Anbieter von Produkten und Dienstleistungen für niedergelassene Humanmediziner, Zahnärzte und Tierärzte. Zudem werden Dentallabors, Kliniken und andere medizinische Einrichtungen betreut. Das Unternehmen mit Hauptsitz in Melville im Bundesstaat New York beschäftigt weltweit über 21.600 Mitarbeiter und hat etwa 800.000 Kunden. Henry Schein ist im Nasdaq börsennotiert und eine Fortune-500-Firma.
Mehr lesen
Henry Schein, Inc. ist ein im Jahr 1932 gegründeter US-amerikanischer Anbieter von Produkten und Dienstleistungen für niedergelassene Humanmediziner, Zahnärzte und Tierärzte. Zudem werden Dentallabors, Kliniken und andere medizinische Einrichtungen betreut. Das Unternehmen mit Hauptsitz in Melville im Bundesstaat New York beschäftigt weltweit über 21.600 Mitarbeiter und hat etwa 800.000 Kunden. Henry Schein ist im Nasdaq börsennotiert und eine Fortune-500-Firma.
Geschichte
Das Unternehmen führt seine Wurzeln auf eine 1932 von Henry und Esther Schein in Woodside (zu Queens im US-Bundesstaat New York gehörend) gegründete Apotheke zurück. 1942 begann Schein mit dem Direktvertrieb von Penizillin, womit eine erste Wachstumsphase begann. Ab den 1950er Jahren verlagerte Schein den Schwerpunkt vom Verbrauchergeschäft auf die Belieferung von Praxen und Laboren. In den 1980er Jahren führte Jay Schein eine weitgehende Automatisierung der gesamten Lieferkette ein, was zu weiterem starkem Wachstum beitrug. Es folgten bis heute zahlreiche Übernahmen von Mitbewerbern. Nach dem Tod von Jay Schein 1989 begann unter der Führung von Stanley M. Bergman der Eintritt in den internationalen Markt (beginnend in Europa). Seit 1995 wird das Unternehmen im Nasdaq gelistet (Kürzel HSIC).
Soziale Verantwortung
Das Bekenntnis von Henry Schein zu gesellschaftlicher Verantwortung hat sich über fast acht Jahrzehnte aus einer tief verwurzelten Familientradition entwickelt und zur Gründung von Henry Schein Cares, dem Corporate-Social-Responsibility-Programm des Unternehmens, geführt. Unter dem Motto „Helping Health Happen“ unterstützt Henry Schein weltweit Aktivitäten, die eine bessere medizinische Versorgung von benachteiligten Bevölkerungsgruppen ermöglichen.
Henry Schein Cares konzentriert sich auf die Weiterentwicklung von drei Bereichen: Prävention und Behandlung, Stärkung der Selbsthilfefähigkeit sowie Katastrophenvorsorge und Nothilfe. Das Wirtschaftsmagazin Fortune hat Henry Schein in der weltweiten Rangliste der „World’s Most Admired Companies“ mit dem ersten Platz seiner Branche in der Kategorie „Soziale Verantwortung“ ausgezeichnet.
In Deutschland unterstützt Henry Schein verschiedene Projekte im Gesundheitsbereich.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
HSIC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
HSIC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
HSIC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 7 28,0%
- Kauf 7 28,0%
- Halten 10 40,0%
- Verkauf 1 4,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
16 Analysten · 2026-08-19Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $1.27 | $1.26 | 0.01% |
| 31. März 2026 | $1.32 | $1.24 | 0.08% |
| 31. Dezember 2025 | $1.34 | $1.33 | 0.01% |
| 30. September 2025 | $1.38 | $1.30 | 0.08% |
| 30. Juni 2025 | $1.10 | $1.22 | -0.12% |
| 31. März 2025 | $1.15 | $1.13 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Wachstumsraten 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | -245,089,515 | 120,199,552 | 121,927,867 | 123,776,073 | -255,840,759 | 126,124,715 | 127,784,380 | 128,720,661 | -269,727 | 130,388,353 | 131,365,789 | -274,191,526 | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | -246,803,540 | 121,036,247 | 122,636,948 | 124,848,221 | -257,691,792 | 127,054,934 | 128,646,506 | 129,769,580 | -401,001 | 131,442,135 | 133,039,886 | -277,434,915 | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Bilanz 24
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Cashflow 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.40B | $13.12B | · | $12.92B | $12.72B | $12.65B | · | $12.64B | $12.57B | $12.49B | · | $12.39B | $12.34B | · | $12.45B | |
| Net Income TTM | $388M | $404M | · | $396M | $399M | $406M | · | $433M | $474M | $491M | · | $548M | $612M | · | $653M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 25.9 | 21.6 | · | 20.6 | 23.2 | 21.6 | · | 21.9 | 17.7 | 20.2 | · | 18.1 | 18.3 | · | 14.3 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| P / FCF | · | -67.6 | · | · | · | 1398.1 | · | · | · | 62.2 | · | · | · | · | · | |
| EV / EBITDA | 40.7 | 34.8 | · | 35.3 | 64.2 | 36.8 | · | 61.6 | 53.5 | 44.0 | · | 47.5 | · | · | · | |
| EV / FCF | · | -75.1 | · | · | · | 1521.4 | · | · | · | 62.9 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.8 | · | · | · | |
| Earnings Yield | 3.9% | 4.6% | · | 4.8% | 4.3% | 4.6% | · | 4.6% | 5.7% | 5.0% | · | 5.5% | 5.5% | · | 7.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Umsatz | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Bruttogewinnmarge % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Betriebsgewinnmarge % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Nettoergebnis | $398M | $390M | $416M | $538M | $631M |
| Verwässerte EPS | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Bilanz
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Liquiditätsgrad | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
Cashflow
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Freier Cashflow | $573M | $700M | $353M | $506M | $631M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 603 Einreicher · $7.6B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 68 (-4 vs. Vorquartal) | 60 (+14 vs. Vorquartal) | 172 (-5 vs. Vorquartal) | 203 (+21 vs. Vorquartal) | +14.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1.307.257.713 | 15.652.032 | 17,12% | Aktien |
| Artisan Partners Limited Partnership | $540.162.844 | 6.467.467 | 7,07% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $530.073.795 | 6.346.669 | 6,94% | Aktien |
| STATE STREET CORP | $359.576.652 | 4.305.276 | 4,71% | Aktien |
| FMR LLC | $349.717.366 | 4.187.229 | 4,58% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345.225.076 | 4.133.442 | 4,52% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $288.743.396 | 3.457.175 | 3,78% | Aktien |
| Southpoint Capital Advisors LP | $275.616.000 | 3.300.000 | 3,61% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $256.689.867 | 3.073.394 | 3,36% | Aktien |
| CITADEL ADVISORS LLC | $243.970.272 | 2.921.100 | 3,20% | Aktien |
| Palestra Capital Management LLC | $204.347.632 | 2.446.691 | 2,68% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $200.544.294 | 2.405.837 | 2,63% | Aktien |
| FIDUCIARY MANAGEMENT INC /WI/ | $151.785.323 | 1.817.353 | 1,99% | Aktien |
| Burgundy Asset Management Ltd. | $151.049.204 | 2.170.871 | 1,98% | Aktien |
| LYRICAL ASSET MANAGEMENT LP | $122.553.156 | 1.467.351 | 1,60% | Aktien |
| Swedbank AB | $109.479.854 | 1.310.822 | 1,43% | Aktien |
| M.D. Sass, LLC | $107.485.396 | 1.286.942 | 1,41% | Aktien |
| SNYDER CAPITAL MANAGEMENT L P | $107.341.992 | 1.285.225 | 1,41% | Aktien |
| NORGES BANK | $103.383.729 | 1.237.832 | 1,35% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86.592.951 | 1.036.793 | 1,13% | Aktien |
| NOMURA HOLDINGS INC | $77.065.658 | 922.721 | 1,01% | Aktien |
| PZENA INVESTMENT MANAGEMENT LLC | $71.888.420 | 860.733 | 0,94% | Aktien |
| Ananym Capital Management, LP | $57.978.164 | 694.183 | 0,76% | Aktien |
| Ulysses Management LLC | $55.570.700 | 665.358 | 0,73% | Aktien |
| STALEY CAPITAL ADVISERS INC | $55.252.489 | 661.548 | 0,72% | Aktien |
| DME Capital Management, LP | $52.173.274 | 624.680 | 0,68% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $45.489.502 | 544.654 | 0,60% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35.970.895 | 430.686 | 0,47% | Aktien |
| GOLDMAN SACHS GROUP INC | $35.392.853 | 423.765 | 0,46% | Aktien |
| Clarkston Capital Partners, LLC | $35.168.100 | 421.074 | 0,46% | Aktien |
| LONE PEAK GLOBAL INVESTORS LLC | $33.404.158 | 399.954 | 0,44% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $30.537.668 | 365.633 | 0,40% | Aktien |
| PRIVATE MANAGEMENT GROUP INC | $27.285.483 | 326.694 | 0,36% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $25.194.142 | 301.654 | 0,33% | Aktien |
| BlackRock, Inc. | $24.670.305 | 295.382 | 0,32% | Aktien |
| GABELLI FUNDS LLC | $24.182.047 | 289.536 | 0,32% | Aktien |
| Zuckerman Investment Group, LLC | $24.062.613 | 288.106 | 0,32% | Aktien |
| JANE STREET GROUP, LLC | $22.976.352 | 275.100 | 0,30% | Kaufoption |
| Petrus Trust Company, LTA | $22.550.400 | 270.000 | 0,30% | Aktien |
| P2 Capital Partners, LLC | $22.089.871 | 264.486 | 0,29% | Aktien |
| BANK OF AMERICA CORP /DE/ | $21.414.277 | 256.397 | 0,28% | Aktien |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $21.151.189 | 253.247 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $21.008.017 | 251.534 | 0,28% | Aktien |
| UBS Group AG | $20.880.000 | 250.000 | 0,27% | Verkaufsoption |
| LAZARD ASSET MANAGEMENT LLC | $20.493.720 | 245.375 | 0,27% | Aktien |
| Cresset Asset Management, LLC | $20.165.236 | 241.442 | 0,26% | Aktien |
| Balyasny Asset Management L.P. | $19.401.863 | 232.302 | 0,25% | Aktien |
| Quantinno Capital Management LP | $18.131.858 | 217.096 | 0,24% | Aktien |
| Vanguard Global Advisers, LLC | $17.149.245 | 205.331 | 0,22% | Aktien |
| FIRST TRUST ADVISORS LP | $16.585.245 | 198.579 | 0,22% | Aktien |
| EVERETT HARRIS & CO /CA/ | $16.551.743 | 198.177 | 0,22% | Aktien |
| California Public Employees Retirement System | $16.351.212 | 195.776 | 0,21% | Aktien |
| Swiss National Bank | $16.344.864 | 195.700 | 0,21% | Aktien |
| Leith Wheeler Investment Counsel Ltd. | $15.975.960 | 191.283 | 0,21% | Aktien |
| WESTWOOD HOLDINGS GROUP INC | $15.708.859 | 188.085 | 0,21% | Aktien |
| Woodline Partners LP | $15.637.951 | 187.236 | 0,20% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.874.912 | 178.100 | 0,19% | Kaufoption |
| Amundi | $14.369.366 | 172.047 | 0,19% | Aktien |
| Stephens Investment Management Group LLC | $14.100.765 | 168.831 | 0,18% | Aktien |
| NUANCE INVESTMENTS, LLC | $14.045.116 | 168.165 | 0,18% | Aktien |
| JANE STREET GROUP, LLC | $13.541.515 | 162.135 | 0,18% | Aktien |
| BARCLAYS PLC | $12.852.476 | 153.885 | 0,17% | Aktien |
| James J. Burns & Company, LLC | $12.843.455 | 153.777 | 0,17% | Aktien |
| Ulysses Management LLC | $12.528.000 | 150.000 | 0,16% | Kaufoption |
| Marathon Asset Management Ltd | $11.609.195 | 139.002 | 0,15% | Aktien |
| CLARK ESTATES INC/NY | $11.275.200 | 135.000 | 0,15% | Aktien |
| PFM Health Sciences, LP | $11.227.009 | 134.423 | 0,15% | Aktien |
| Holocene Advisors, LP | $10.191.528 | 122.025 | 0,13% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $10.070.173 | 120.572 | 0,13% | Aktien |
| HEARTLAND ADVISORS INC | $10.022.400 | 120.000 | 0,13% | Aktien |
| BANK OF NOVA SCOTIA | $9.519.692 | 113.981 | 0,12% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $9.502.822 | 113.779 | 0,12% | Aktien |
| HFR Wealth Management, LLC | $9.454.965 | 113.206 | 0,12% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9.138.210 | 123.992 | 0,12% | Aktien |
| Illinois Municipal Retirement Fund | $8.914.173 | 106.731 | 0,12% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $8.898.137 | 106.539 | 0,12% | Aktien |
| Clearline Capital LP | $8.696.854 | 104.129 | 0,11% | Aktien |
| Stenger Family Office, LLC | $8.511.793 | 24.721 | 0,11% | Aktien |
| FIRST MANHATTAN CO. LLC. | $8.509.769 | 101.889 | 0,11% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8.184.793 | 97.998 | 0,11% | Aktien |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $8.101.440 | 97.000 | 0,11% | Aktien |
| Man Group plc | $7.975.325 | 95.490 | 0,10% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $7.705.472 | 92.259 | 0,10% | Aktien |
| BANYAN CAPITAL MANAGEMENT, INC. | $7.621.951 | 91.259 | 0,10% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $7.521.178 | 90.052 | 0,10% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $6.802.084 | 81.443 | 0,09% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $6.719.450 | 91.173 | 0,09% | Aktien |
| FRANKLIN RESOURCES INC | $6.613.615 | 79.186 | 0,09% | Aktien |
| Berger Financial Group, Inc | $6.535.023 | 78.245 | 0,09% | Aktien |
| WINTON GROUP Ltd | $6.439.392 | 77.100 | 0,08% | Aktien |
| RIVER GLOBAL INVESTORS LLP | $6.404.253 | 92.547 | 0,08% | Aktien |
| Brandywine Global Investment Management, LLC | $6.305.262 | 83.425 | 0,08% | Aktien |
| Foyston, Gordon & Payne Inc | $6.304.173 | 75.481 | 0,08% | Aktien |
| Allianz Asset Management GmbH | $6.210.714 | 74.362 | 0,08% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.145.736 | 73.584 | 0,08% | Aktien |
| AdvisorShares Investments LLC | $5.879.892 | 70.401 | 0,08% | Aktien |
| PNC Financial Services Group, Inc. | $5.687.294 | 68.095 | 0,07% | Aktien |
| Squarepoint Ops LLC | $5.369.083 | 64.285 | 0,07% | Aktien |
| Cinctive Capital Management LP | $5.110.088 | 61.184 | 0,07% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $4.965.598 | 59.454 | 0,07% | Aktien |
Unternehmensinsider 51 Insider · 23 Führungskräfte · 21 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 10. Dezember 2025 F | 65.900 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19. März 2025 S | 62.688 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 14. März 2025 D | 36.257 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12. Juni 2023 S | 68.690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2. März 2018 A | 62.902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15. März 2016 S | 31.000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 14. März 2025 D | 81.374 | 0 | 0 | $0 |
| James P Breslawski | President | 14. März 2025 D | 200.227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 6. März 2017 A | 9.654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 7. März 2013 M | 48.716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 19. November 2025 G | 101.622 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16. März 2026 F | 98.372 | 0 | 2 | $-478.758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14. März 2025 D | 43.191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 6. September 2024 S | 71.833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26. Mai 2022 S | 95.616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30. November 2018 S | 68.012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 6. September 2017 S | 17.841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12. Mai 2017 S | 22.943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20. März 2017 M | 23.088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13. März 2017 S | 14.277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 8. März 2017 S | 16.589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2. März 2016 F | 25.144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17. März 2015 S | 12.343 | 0 | 0 | $0 |
| William K Daniel | Direktor | 12. Juni 2026 A | 7.641 | 1 | 0 | $691.900 |
| Bradley T Sheares | Direktor | 6. März 2026 A | 47.623 | 0 | 0 | $0 |
| Philip A Laskawy | Direktor | 6. März 2026 A | 24.538 | 0 | 1 | $-228.544 |
| Reed Vaughn Tuckson | Direktor | 11. Juni 2025 F | 9.943 | 0 | 0 | $0 |
| Carol Raphael | Direktor | 21. Mai 2025 F | 33.538 | 0 | 0 | $0 |
| Anne H. Margulies | Direktor | 5. März 2025 F | 20.576 | 0 | 0 | $0 |
| Scott Philip Serota | Direktor | 4. März 2025 A | 8.213 | 0 | 0 | $0 |
| Carole T Faig | Direktor | 4. März 2025 A | 5.448 | 0 | 0 | $0 |
| Mohamad Ali | Direktor | 4. März 2025 A | 12.498 | 0 | 0 | $0 |
| Robert J. Hombach | Direktor | 4. März 2025 A | 2.844 | 0 | 0 | $0 |
| Steven Paladino | Direktor | 4. März 2024 A | 138.272 | 0 | 0 | $0 |
| Dianne E Rekow | Direktor | 16. März 2022 A | 18.526 | 0 | 0 | $0 |
| Barry J Alperin | Direktor | 16. März 2022 A | 52.473 | 0 | 0 | $0 |
| Paul Brons | Direktor | 3. März 2021 F | 16.854 | 0 | 0 | $0 |
| Shira Goodman | Direktor | 3. März 2021 A | 5.689 | 0 | 0 | $0 |
| Lawrence S Bacow | Direktor | 6. März 2018 F | 10.115 | 0 | 0 | $0 |
| Donald J Kabat | Direktor | 6. März 2018 F | 10.874 | 0 | 0 | $0 |
| Louis W Sullivan | Direktor | 31. März 2016 A | 14.096 | 0 | 0 | $0 |
| Norman S Matthews | Direktor | 31. März 2016 A | 12.890 | 0 | 0 | $0 |
| Karyn Mashima | Direktor | 10. März 2014 F | 19.269 | 0 | 0 | $0 |
| Irving Shafran | Direktor | 20. November 2003 S | 750.000 | 0 | 0 | $0 |
| HENRY SCHEIN INC | 10%-Eigentümer | 7. Februar 2019 J | 0 | 0 | 0 | $0 |
| Stanley M Bergman | — | 26. Mai 2026 G | 253.279 | 0 | 5 | $-7.544.687 |
| Kurt P Kuehn | — | 10. März 2026 S | 15.420 | 0 | 1 | $-224.562 |
| Deborah Derby | — | 6. März 2026 A | 15.093 | 0 | 0 | $0 |
| Joseph L Herring | — | 6. März 2026 A | 30.325 | 0 | 0 | $0 |
| Margaret A Hamburg | — | 20. Mai 2009 M | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 Einreichungen | 10. März 2026 | 16,40% | Änderung | — | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 Einreichungen | 8. August 2025 | 13,00% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 124 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,69% | 150.301 SH | 8. August 2026 | Täglich |
| FLV · AMERICAN CENTURY ETF TRUST | 1,67% | 76.819 NS | 31. Mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,31% | 154.050 NS | 30. April 2026 | N-PORT |
| GURU · Global X Funds | 1,05% | 8.187 NS | 30. April 2026 | N-PORT |
| TAX · EA Series Trust | 0,98% | 3.244 NS | 29. Mai 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,64% | 123.268 SH | 8. August 2026 | Täglich |
| SMMV · iShares Trust | 0,60% | 19.668 SH | 8. August 2026 | Täglich |
| FBCV · FIDELITY COVINGTON TRUST | 0,35% | 7.509 NS | 30. April 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,31% | 13.083 NS | 30. April 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 17.947 NS | 30. April 2026 | N-PORT |
| ANEW · ProShares Trust | 0,28% | 283 NS | 31. Mai 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 55.872 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,26% | 20.602 SH | 8. August 2026 | Täglich |
| DEUS · DBX ETF Trust | 0,22% | 7.905 NS | 29. Mai 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,22% | 4.614 NS | 31. Mai 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.354.606 SH | 8. August 2026 | Täglich |
| DFVE · DoubleLine ETF Trust | 0,21% | 765 NS | 31. März 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,20% | 181 NS | 31. Mai 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,20% | 16.567 NS | 30. April 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,18% | 245 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58.273 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,18% | 333.590 NS | 30. April 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 55.767 NS | 30. April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1.416.056 SH | 8. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 42.689 NS | 30. April 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,14% | 270.326 NS | 31. Mai 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 4.118 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 58.901 SH | 8. August 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 24.631 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,13% | 4.208 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 48.980 NS | 30. April 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 21.075 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293.098 SH | 8. August 2026 | Täglich |
| SMMD · iShares Trust | 0,12% | 49.577 SH | 8. August 2026 | Täglich |
| RXL · ProShares Trust | 0,11% | 1.043 NS | 31. Mai 2026 | N-PORT |
| IXJ · iShares Trust | 0,11% | 51.636 SH | 8. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,11% | 1.994 NS | 30. April 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.230.411 SH | 8. August 2026 | Täglich |
| IEDI · iShares U.S. ETF Trust | 0,10% | 316 SH | 8. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 9.299 SH | 8. August 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7.550 SH | 8. August 2026 | Täglich |
| IWS · iShares Trust | 0,08% | 148.171 SH | 8. August 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,08% | 146.387 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 5.958 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,08% | 20.790 NS | 30. April 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 82.484 SH | 8. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7.214 SH | 8. August 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6.605 NS | 30. April 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 401.448 SH | 8. August 2026 | Täglich |
| JSTC · Tidal Trust I | 0,06% | 2.708 NS | 31. Mai 2026 | N-PORT |